Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic

Area of Science:

• Neurology
• Public Health
• Infectious Diseases

Background:

• The COVID-19 pandemic has significantly impacted global healthcare systems and patient care.
• Cerebrovascular events represent a major global health challenge, causing significant mortality and long-term disability, particularly in Europe.
• Addressing the dual burden of the pandemic and cerebrovascular disease necessitates a strategic approach to secondary prevention.

Purpose of the Study:

• To outline recommendations for managing cerebrovascular events during the COVID-19 pandemic.
• To emphasize the importance of secondary prevention strategies for cerebrovascular disease in the context of the pandemic.
• To highlight the role of primary and secondary prevention in mitigating the impact of COVID-19 waves.

Main Methods:

• This study provides recommendations based on current understanding of both COVID-19 and cerebrovascular disease management.
• The approach integrates established secondary prevention protocols with pandemic-specific considerations.
• Guidance is informed by public health directives and clinical best practices.

Main Results:

• Patients must seek immediate medical attention for acute cerebrovascular events to ensure timely secondary prevention and reperfusion therapies.
• Consistent adherence to prescribed secondary prevention measures is vital for patients with cerebrovascular disease.
• Proactive cerebrovascular prevention may reduce the overall burden of COVID-19.

Conclusions:

• Urgent medical care for cerebrovascular events remains critical during pandemic waves, ensuring access to secondary prevention and acute treatments.
• Patient adherence to secondary prevention guidelines and government/physician pandemic advice is paramount.
• Optimizing both primary and secondary cerebrovascular prevention can lessen the impact of COVID-19, both currently and in future waves.